Filing Details

Accession Number:
0001127602-10-029823
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-12-06 20:19:55
Reporting Period:
2010-12-02
Filing Date:
2010-12-06
Accepted Time:
2010-12-06 20:19:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
318154 Amgen Inc AMGN Biological Products, (No Disgnostic Substances) (2836) 953540776
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1491654 J.w. Thomas Dittrich One Amgen Center Drive
M/S 28-5-C
Thousand Oaks CA 91320
Vp, Finance & Cao No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-12-02 3,500 $53.60 8,624 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,500 RSUs which vest on 7/31/2011; 1,714 RSUs which vest in two equal annual installments of 857 each commencing 4/29/2011; 858 RSUs which vest in three equal annual installments of 286 each commencing 4/28/2011; and 1,229 RSUs which vest in three equal annual installments of 307 each on 4/26/2011, 4/26/2012 and 4/26/2013 and one installment of 308 on 4/26/2014. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.